FFRct vs Tempus ECG-Low EF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, HeartFlow FFRct Analysis, focuses on diagnosing coronary artery disease by creating personalized 3D models from CCTA scans to assess blood flow. In contrast, Tool B, Tempus ECG-Low EF, analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction, aiding in the identification of heart failure risk. While both are AI-powered cardiology tools, they utilize different input modalities and target distinct cardiac conditions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is designed to aid in diagnosing coronary artery disease (CAD) and guiding treatment strategies by assessing blood flow in personalized 3D models of coronary arteries. Tempus ECG-Low EF is an AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure, assisting clinicians in further evaluation.
HeartFlow FFRct Analysis utilizes data from CCTA (Coronary Computed Tomography Angiography) scans to create its 3D models and assess blood flow. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings.
HeartFlow FFRct generates personalized 3D digital models of coronary arteries, providing FFRct values to analyze blood flow and identify areas of narrowing. Tempus ECG-Low EF provides a binary output, indicating either 'Low LVEF Detected' or 'Not Detected'.
HeartFlow FFRct Analysis is primarily intended for use by Cardiology and Radiology specialists. Tempus ECG-Low EF is designed for use by Cardiology, Emergency Medicine, and Internal Medicine specialists.
More Comparisons
Backers
Who funded each tool's parent company.